Epstein-Barr Virus
Epstein-Barr virus vector mediates gene transfer into human B cells
Published in Gene Therapy Weekly, March 16th, 2006
"The efficient gene transfer of immunostimulatory cytokines into autologous tumor cells or the transfer of tumor-associated antigens into professional antigen-presenting cells is a prerequisite for many immunotherapeutic approaches."
"In particular with B cells, the efficiency of gene uptake is one of the limiting factors in cell-based vaccine strategies, since normal and malignant human B cells are commonly refractory to transducing gene vectors. Due to its natural tropism for human B cells, EBV, a human herpes virus, might be an...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-03-16)
More Articles from Gene Therapy Weekly
- Alzheimer Disease
Acetylcholinesterase antisense inhibition may treat cognition deficit - Cancer Gene Therapy
Carcinoma-specific promoter controls efficient and selective adenoviral gene expression - Gene Silencing
Adenovirus-mediated small-interference RNA silences angiotensin AT(1a) receptors - Gene Transfer
Adenovirus-mediated gene transfer reveals pathways of HAS1 activation - RNA Interference
Protein-coding genes and short hairpin RNAs are simultaneously expressed in mammalian cells - Antisense Technology
Antisense oligodeoxynucleotides and diet eliminate resistant melanoma cells - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
